Exai: Exai Bio Presents New Non-Small Cell Lung Cancer Early Detection Data at the American Association for Cancer Research (AACR) 2023 Annual Meeting

Exai Bio is a California-based biotechnology company that develops oncRNA and AI-driven liquid biopsy technology for the treatment of cancer diagnosis.